We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£885.00
The 2026-2031 World Outlook for Antidepressants for Anxiety Disorders
Price data last checked 149 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£885 today · cheaper than every other day in the last 11 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 193 days • 193 data points (No recent data available)
Price Distribution
Price distribution over 193 days • 1 price levels
Price Analysis
Most common price: £885 (193 days, 100.0%)
Price range: £885 - £885
Price levels: 1 different prices over 193 days
Product Specifications
- Format
- paperback
- ASIN
- B0FFSXFRR2
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 04 June 2025
- Listed Since
- 27 June 2025
Similar Products You Might Like
The 2023-2028 Outlook for Antidepressants for Anxiety Disorders in the United States
The 2026-2031 World Outlook for Antidepressant and Anti-Anxiety Drugs
The 2026-2031 World Outlook for Antidepressants
The 2026-2031 World Outlook for Antidepressant Drugs
The 2026-2031 World Outlook for Antidepressant Pharmaceuticals
The 2021-2026 World Outlook for Antidepressants
The 2023-2028 Outlook for Anxiety Disorders and Depression Treatments in the United States
The 2023-2028 Outlook for Anxiety Disorders and Depression in the United States
The 2023-2028 Outlook for Anxiety Disorder Therapeutics in the United States
The 2016-2021 Outlook for Antidepressant Pharmaceuticals in Japan
The 2023-2028 Outlook for Antidepressants for Major Depressive Disorders in the United States
The 2023-2028 Outlook for Anxiety Disorder Treatments in the United States
The 2026-2031 World Outlook for Antidepressants for Major Depressive Disorders
The 2021-2026 World Outlook for Psychotherapeutic Agents Excluding Tranquilizers and Antidepressants
The 2016-2021 Outlook for Prescription Non-Barbituate Anxiolytic and Hypnotic Sedatives in the United States
Antidepressants: Perspectives, Medical Uses & Health Implications (Pharmacology - Research, Safety Testing and Regualtion)
The 2016-2021 Outlook for Prescription Non-Barbituate Anxiolytic and Hypnotic Sedatives in Japan
Anxiety Disorders: From Childhood to Adulthood
IntechOpen
The 2016-2021 Outlook for Topical Antiseptic Medications in the United States
The 2023-2028 Outlook for Stress Management Treatments in the United States
Anxiety and Depression in Primary Care: International Perspectives (WONCA Family Medicine)
CRC Press
The Self in Anxiety, Stress and Depression
North Holland
Treatments for Anxiety: Fact versus Fiction
Bloomsbury Academic
